Scott McMeekin

2.5k total citations
37 papers, 1.9k citations indexed

About

Scott McMeekin is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Scott McMeekin has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Reproductive Medicine, 13 papers in Surgery and 11 papers in Obstetrics and Gynecology. Recurrent topics in Scott McMeekin's work include Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Intraperitoneal and Appendiceal Malignancies (9 papers). Scott McMeekin is often cited by papers focused on Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Intraperitoneal and Appendiceal Malignancies (9 papers). Scott McMeekin collaborates with scholars based in United States, Italy and United Kingdom. Scott McMeekin's co-authors include Dennis R. Scribner, Robert S. Mannel, Michael A. Gold, Joan L. Walker, Philip J. DiSaia, Gary A. Johnson, Alan N. Gordon, Michael Teneriello, Yanping Wang and Mauro Orlando and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Scott McMeekin

37 papers receiving 1.8k citations

Peers

Scott McMeekin

SURGE

ONCOL

Carmela Pisano Italy

W Gajewski United States

M. Baekelandt Norway

Frederick R. Ueland United States

Monica B. Jones United States

Fabian Trillsch Germany

Vanda Salutari Italy

Malgorzata Tuxen Denmark

Toshiko Jobo Japan

Sabrina Chiara Cecere Italy

Carmela Pisano Italy

Scott McMeekin

862 ×1.0

532 ×1.0

447 ×0.9

321 ×0.7

SURGE

706 ×1.7

ONCOL

Citations per year, relative to Scott McMeekin Scott McMeekin (= 1×) peers Carmela Pisano

Countries citing papers authored by Scott McMeekin

Since Specialization

Citations

This map shows the geographic impact of Scott McMeekin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott McMeekin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott McMeekin more than expected).

Fields of papers citing papers by Scott McMeekin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott McMeekin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott McMeekin. The network helps show where Scott McMeekin may publish in the future.

Co-authorship network of co-authors of Scott McMeekin

This figure shows the co-authorship network connecting the top 25 collaborators of Scott McMeekin. A scholar is included among the top collaborators of Scott McMeekin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott McMeekin. Scott McMeekin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chakraborty, Prabir K., Soumyajit Banerjee Mustafi, Xunhao Xiong, et al.. (2017). MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nature Communications. 8(1). 14634–14634. 137 indexed citations

Dao, Fanny, Brooke A. Schlappe, Jill Tseng, et al.. (2016). Characteristics of 10-year survivors of high-grade serous ovarian carcinoma. Gynecologic Oncology. 141(2). 260–263. 78 indexed citations

Wang, Yunzhi, Theresa Thai, Kathleen N. Moore, et al.. (2016). Quantitative measurement of adiposity using CT images to predict the benefit of bevacizumab-based chemotherapy in epithelial ovarian cancer patients. Oncology Letters. 12(1). 680–686. 16 indexed citations

Srivastava, Akhil, Justyna Filant, Katherine Moxley, et al.. (2015). Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment. Current Gene Therapy. 15(2). 182–192. 75 indexed citations

McMeekin, Scott, Don S. Dizon, James Barter, et al.. (2015). Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer. Gynecologic Oncology. 138(1). 18–23. 59 indexed citations

Matulonis, Ursula A., Ignace Vergote, Floor Backes, et al.. (2014). Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma. Gynecologic Oncology. 136(2). 246–253. 88 indexed citations

Xiong, Xunhao, Rochelle R. Arvizo, Sounik Saha, et al.. (2014). Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles. Oncotarget. 5(15). 6453–6465. 63 indexed citations

Martin, Lainie P., et al.. (2013). Phase II study of weekly PM00104 (ZALYPSIS®) in patients with pretreated advanced/metastatic endometrial or cervical cancer. Medical Oncology. 30(3). 627–627. 14 indexed citations

Pant, Shubham, Howard A. Burris, Kathleen N. Moore, et al.. (2013). A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors. Investigational New Drugs. 32(1). 87–93. 9 indexed citations

10.

Campo, José María Del, Cristiana Sessa, Carolyn Krasner, et al.. (2013). Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials. Medical Oncology. 30(1). 435–435. 28 indexed citations

11.

Gordon, Alan N., Michael Teneriello, Mike F. Janicek, et al.. (2011). Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer. Gynecologic Oncology. 123(3). 479–485. 17 indexed citations

12.

McMeekin, Scott, Ravi Patel, Claire F. Verschraegen, et al.. (2011). Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer. British Journal of Cancer. 106(1). 70–76. 12 indexed citations

13.

Schilder, Russell J., John A. Blessing, Mark S. Shahin, et al.. (2010). A Phase 2 Evaluation of Irofulven as Second-line Treatment of Recurrent or Persistent Intermediately Platinum-Sensitive Ovarian or Primary Peritoneal Cancer A Gynecologic Oncology Group Trial. International Journal of Gynecological Cancer. 20(7). 1137–1141. 11 indexed citations

14.

DeGeest, Koen, et al.. (2007). A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: A Gynecologic Oncology Group study. Gynecologic Oncology. 107(2). 274–279. 30 indexed citations

15.

Mannel, Robert S., Joan L. Walker, Natalie Gould, et al.. (2003). Impact of Individual Physicians on Enrollment of Patients into Clinical Trials. American Journal of Clinical Oncology. 26(2). 171–173. 39 indexed citations

16.

Chan, John K., Bradley J. Monk, Casey Brewer, et al.. (2003). HPV infection and number of lifetime sexual partners are strong predictors for ‘natural’ regression of CIN 2 and 3. British Journal of Cancer. 89(6). 1062–1066. 42 indexed citations

17.

Burger, Robert A., Bradley J. Monk, Scott McMeekin, et al.. (2001). Bowel Resection at The Time of Primary Cytoreduction for Epithelial Ovarian Cancer. Journal of the American College of Surgeons. 193(6). 626–632. 61 indexed citations

18.

Scribner, Dennis R., Joan L. Walker, Gary A. Johnson, et al.. (2001). Surgical Management of Early-Stage Endometrial Cancer in the Elderly: Is Laparoscopy Feasible?. Gynecologic Oncology. 83(3). 563–568. 116 indexed citations

19.

Scribner, Dennis R., Joan L. Walker, Gary A. Johnson, et al.. (2001). Laparoscopic Pelvic and Paraaortic Lymph Node Dissection: Analysis of the First 100 Cases. Gynecologic Oncology. 82(3). 498–503. 72 indexed citations

20.

Bloss, Jeffrey D., Shu‐Yuan Liao, Richard E. Buller, et al.. (1993). Extraovarian Peritoneal Serous Papillary Carcinoma: A Case-Control Retrospective Comparison to Papillary Adenocarcinoma of the Ovary. Gynecologic Oncology. 50(3). 347–351. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact